Regenxbio (RGNX) Non-Current Assets (2014 - 2025)

Regenxbio's Non-Current Assets history runs 12 years deep, the most recent figure standing at $171.8 million for Q4 2025.

• In Q4 2025, Non-Current Assets fell 8.64% year-over-year to $171.8 million; the TTM figure through Dec 2025 stood at $750.0 million (down 11.79% YoY), while the FY2025 annual figure was $171.8 million, down 8.64% from the prior year.
• Non-Current Assets was $171.8 million for Q4 2025 at Regenxbio, down from $193.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $595.1 million in Q4 2021 to a low of $171.8 million in Q4 2025.
• Historically, Non-Current Assets has averaged $323.3 million across 5 years, with a median of $285.8 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Non-Current Assets surged 236.26% in 2021, then plunged 42.73% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $595.1 million in 2021, then retreated by 29.88% to $417.3 million in 2022, then tumbled by 42.73% to $239.0 million in 2023, then dropped by 21.34% to $188.0 million in 2024, then decreased by 8.64% to $171.8 million in 2025.
• The last three Non-Current Assets figures came in at $171.8 million (Q4 2025), $193.2 million (Q3 2025), and $207.3 million (Q2 2025), per Business Quant data.